PIM 2.0: Patient Aligned Care Team (PACT) Intensive Management (PIM) Project

计划入组 599 人 · 首次发布于 2020 年 8 月 21 日

A Controlled Human Pneumococcal Infection Model (PIM) Study

计划入组 20 人 · 首次发布于 2022 年 5 月 4 日

Patient Aligned Care Team (PACT) Intensive Management (PIM) Project

计划入组 2,210 人 · 首次发布于 2017 年 4 月 4 日

PIM-35

SEL-24

C₁₅H₁₈Br₂N₄O₂

FLT3 TriTAC

Janssens Wim

Belgium

Kim, Edward

United States

HYUNJOONG KIM

Australia

First Patient Dosed in Phase II JASPIS-01 Trial of Dapolsertib for Relapsed/Refractory DLBCL

Ryvu Therapeutics Partners with BioNTech to Accelerate Cancer Immunotherapy Trials in Poland

Ryvu Therapeutics Presents Promising Clinical Data on Romaciclib and Dapolsertib at ASH 2025